MilanJAnadkatMD
Dermatology • Saint Louis, MOProfessor, Dermatology Director of Dermatology Clinical Trials, Washington University School of Medicine
Dr. Anadkat is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4901 Forest Park Ave
Saint Louis, MO 63108Phone(314) 362-2643Fax(314) 747-8693- Is this information wrong?
Summary
- Dr. Milan Anadkat is a dermatologist in Saint Louis, MO and is affiliated with multiple hospitals in the area, including Barnes-Jewish Hospital and Siteman Cancer Center. He received his medical degree from Northeast Ohio Medical University and has been in practice 16 years. He is experienced in general and complex medical dermatology, chemotherapy related skin toxicity, autoimmune bulls disease, hidradenitis, and graft-versus-host disease.
Education & Training
Barnes-Jewish HospitalResidency, Dermatology, 2004 - 2007- Barnes-Jewish HospitalInternship, Internal Medicine, 2001 - 2002
Northeast Ohio Medical UniversityClass of 2001
Certifications & Licensure
MO State Medical License 2002 - 2022- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis Start of enrollment: 2020 Jun 04
- Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash Start of enrollment: 2008 Apr 01Cliff Perlis, MD;Jennifer Temel, MD;Madeline Duvic, MD;Maria Colavincenzo, MD;Milan Anadkat, MD;Serena Mraz, MD;Vera Hirsh, MD
Publications & Presentations
PubMed
- Reducing Skin Toxicities from EGFR Inhibitors with Topical BRAF Inhibitor TherapyMario E. Lacouture, Zev A. Wainberg, Anisha B. Patel, Milan J. Anadkat, Salomon M. Stemmer, Einat Shacham-Shmueli, Egmidio Medina, Galit Zelinger, Noa Shelach, Antoni ...> ;Cancer Discovery. 2021 Apr 28
- Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines.Mario E. Lacouture, Vincent Sibaud, Milan J. Anadkat, Benjamin H. Kaffenberger, Jonathan S. Leventhal, Kathleen Guindon, Ghassan K. Abou-Alfa> ;Oncologist. 2021 Feb 1
- Pemphigus foliaceus in a patient with gastrointestinal stromal tumor treated with adjuvant imatinib mesylate.Hal A. Lewis, David Y. Chen, Ilana S. Rosman, Joel Picus, Milan J. Anadkat> ;Dermatology Online Journal. 2020 Jun 15
- Join now to see all
Journal Articles
- Calcinosis Cutis in the Setting of Chronic Skin Graft-Versus-Host DiseaseKarl M Saardi, Rachel K Rosenstein, Milan J Anadkat, JAMA Dermatology
Lectures
- Dermatologic Findings in the Stem Cell Transplant PatientAmerican Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/4/2019
- Inflammatory Bowel Disease 2013Washington University School of Medicine, Saint Louis, Missouri - 6/8/2013
- Florida Society of Dermatology & Dermatologic Surgery (FSDDS) 2012 Annual MeetingFlorida Society of Dermatology & Dermatologic Surgery, Orlando, Florida - 5/25/2012
Authored Content
- Calcinosis Cutis in the Setting of Chronic Skin Graft-Versus-Host DiseaseMay 2020
Press Mentions
Study Adds Evidence on the Link Between Leukemia Cutis and Poor Prognosis in AMLMay 6th, 2019
Professional Memberships
- Fellow
Hospital Affiliations
Barnes-Jewish HospitalSaint Louis, Missouri- Siteman Cancer CenterSaint Louis, Missouri
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
